Axsome Therapeutics's total assets for Q2 2025 were $639.78M, an increase of 7.23% from the previous quarter. AXSM total liabilities were $566.71M for the fiscal quarter, a 4.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.